Dakota Wealth Management Bristol Myers Squibb CO Transaction History

Dakota Wealth Management

$4.18 Billion
Q2 2024

A detailed history of Dakota Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dakota Wealth Management holds 56,165 shares of BMY stock, worth $2.99 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

56,165

Previous 46,417 21.0%

Holding current value

$2.99 Million

Previous $2.52 Million 7.35%

% of portfolio

0.06%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$40.25 - $52.99 $392,357 - $516,546	9,748 Added 21.0%	56,165 $2.33 Million
Q1 2024 Apr 24, 2024	BUY	$47.98 - $54.4 $1.3 Million - $1.48 Million	27,158 Added 141.01%	46,417 $2.52 Million
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $221,117 - $263,853	-4,561 Reduced 19.15%	19,259 $988,000
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $197,868 - $221,247	-3,418 Reduced 12.55%	23,820 $1.38 Million
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $45,425 - $50,437	713 Added 2.69%	27,238 $1.74 Million
Q1 2023 Apr 14, 2023	SELL	$65.71 - $74.53 $353,191 - $400,598	-5,375 Reduced 16.85%	26,525 $1.84 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $598,104 - $708,240	-8,734 Reduced 21.49%	31,900 $2.29 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $2,499 - $1.48 Million	19,225 Added 89.8%	40,634 $2.89 Million
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $1.23 Million - $1.35 Million	16,869 Added 371.56%	21,409 $1.65 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $279,119 - $334,688	4,540 New	4,540 $332,000
Q2 2021 Aug 02, 2021	SELL	$61.91 - $67.42 $704,969 - $767,711	-11,387 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $18,870 - $21,223	-318 Reduced 2.72%	11,387 $719,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $675,846 - $765,858	11,705 New	11,705 $726,000
Q1 2019 Apr 18, 2019	SELL	$45.12 - $53.8 $251,318 - $299,666	-5,570 Closed	0 $0
Q4 2018 Jan 22, 2019	SELL	$48.76 - $63.23 $9,800 - $12,709	-201 Reduced 3.48%	5,570 $339,000
Q3 2018 Nov 07, 2018	BUY	$55.19 - $62.25 $19,647 - $22,161	356 Added 6.57%	5,771 $359,000
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $273,619 - $341,036	5,415 New	5,415 $299,000

Others Institutions Holding BMY

# of Institutions

2,425

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dakota Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Dakota Wealth Management with notifications on news.

Account

Dakota Wealth Management Bristol Myers Squibb CO Transaction History